Score Overview
Explore the 2021 public Archive ranking →
Where Champions Oncology Inc has ranked, year by year
Showing 5 years ranking history by HDB Score.
Has not reached the top 50 on HDB Score in any year we have ranked.
- CSBR
2009: 98.7% · 2021: 16.1% · free through 2021 · longest runs
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-10-01 | $ 4.88 | — |
1 Year2025-10-01 | $ 6.40 | -23.75% |
5 Years2021-10-01 | $ 9.96 | -51.00% |
10 Years2016-09-30 | $ 1.68 | 190.48% |
20 Years2006-09-25 | $ 0.01 | 325x |
30 Years1996-10-01 | $ 0.12 | 41x |
All Time2003-01-10 | $ 0.01 | 325x |
| Period | Last Price2026-10-01 | 1 Year2025-10-01 | 5 Years2021-10-01 | 10 Years2016-09-30 | 20 Years2006-09-25 | 30 Years1996-10-01 | All Time2003-01-10 |
|---|---|---|---|---|---|---|---|
| Price | $ 4.88 | $ 6.40 | $ 9.96 | $ 1.68 | $ 0.01 | $ 0.12 | $ 0.01 |
| Return | — | -23.75% | -51.00% | 190.48% | 325x | 41x | 325x |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
Reported in USD
| Year | |||
|---|---|---|---|
| TTM | $ 60M | -$ 1M | $ 4M |
| 2026 | $ 59M | -$ 1M | $ 4M |
| 2025 | $ 56M | $ 4M | $ 9M |
| 2024 | $ 50M | -$ 7M | $ 2M |
| 2023 | $ 53M | -$ 5M | $ 10M |
| 2022 | $ 49M | $ 548K | $ 9M |
| 2021 | $ 41M | $ 362K | $ 4M |
| 2020 | $ 32M | -$ 2M | $ 8M |
| 2019 | $ 27M | $ 128K | $ 3M |
| 2018 | $ 20M | -$ 1M | $ 856K |
| 2017 | $ 15M | -$ 6M | $ 3M |
| 2016 | $ 11M | -$ 10M | $ 2M |
| 2015 | $ 8M | -$ 13M | $ 9M |
| 2014 | $ 11M | -$ 7M | $ 5M |
| 2013 | $ 8M | -$ 6M | $ 9M |
| 2012 | $ 7M | -$ 8M | $ 4M |
| 2011 | $ 6M | -$ 3M | $ 10M |
| 2010 | $ 4M | -$ 2M | $ 2M |
| 2009 | $ 3M | -$ 2M | $ 2M |
| 2008 | $ 1M | -$ 411K | $ 3M |
| 2007 | -$ 170.06K | $ 3.76K | |
| 2006 | -$ 303.72K | $ 540.00 | |
| 2005 | $ 1M | -$ 246.54K | $ 84.51K |
| 2004 | $ 1M | -$ 107.69K | $ 120.12K |
| IPO2003 | $ 2M | -$ 145.99K | $ 195.1K |
Champions Oncology Inc fundamental performance
Between 2016 and 2026, revenue grew from $ 11M to $ 59M and net income went from -$ 10M to -$ 1M. Revenue increased in 9 of those 10 years; net income in 6.
Across Champions Oncology Inc's full reported history, from 2003 to 2026, revenue grew from $ 2M to $ 59M and net income went from -$ 145.99K to -$ 1M. Revenue increased in 81% of the years measured; net income in 46%.
Champions Oncology Inc currently holds a 5-year HDB Score of 3.8 out of 10. How the HDB Score is calculated.
Membership
Continue CSBR’s history
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 3,813 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio
